CAMBRIDGE, Mass.--(BUSINESS WIRE)--CombinatoRx, Incorporated (NASDAQ: CRXX) today announced that Annals of the Rheumatic Diseases has published the results of its CRx-102 Phase 2a hand osteoarthritis trial. The manuscript entitled “Efficacy and Safety of a Novel Synergistic Drug Candidate – CRx-102 – in Hand Osteoarthritis”, Kvien, et.al. was pre-published on-line (http://ard.bmj.com/onlinefirst.dtl) and will run in an upcoming print edition. Annals of Rheumatic Diseases is the peer reviewed European League Against Rheumatism (EULAR) journal for rheumatic disease health professionals and researchers.
